BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 20007851)

  • 1. Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice.
    Shen Z; Liang X; Rogers CQ; Rideout D; You M
    Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G364-74. PubMed ID: 20007851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of peroxisome proliferator-activated receptor-γ by rosiglitazone improves lipid homeostasis at the adipose tissue-liver axis in ethanol-fed mice.
    Sun X; Tang Y; Tan X; Li Q; Zhong W; Sun X; Jia W; McClain CJ; Zhou Z
    Am J Physiol Gastrointest Liver Physiol; 2012 Mar; 302(5):G548-57. PubMed ID: 22173916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adiponectin-SIRT1-AMPK pathway in alcoholic fatty liver disease in the rat.
    Jiang Z; Zhou J; Zhou D; Zhu Z; Sun L; Nanji AA
    Alcohol Clin Exp Res; 2015 Mar; 39(3):424-33. PubMed ID: 25703252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol alleviates alcoholic fatty liver in mice.
    Ajmo JM; Liang X; Rogers CQ; Pennock B; You M
    Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G833-42. PubMed ID: 18755807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-
    Reyes-Gordillo K; Shah R; Varatharajalu R; Garige M; Leckey LC; Lakshman MR
    Oxid Med Cell Longev; 2016; 2016():1840513. PubMed ID: 28074114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.
    Yin H; Hu M; Liang X; Ajmo JM; Li X; Bataller R; Odena G; Stevens SM; You M
    Gastroenterology; 2014 Mar; 146(3):801-11. PubMed ID: 24262277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethanol administration exacerbates the abnormalities in hepatic lipid oxidation in genetically obese mice.
    Everitt H; Hu M; Ajmo JM; Rogers CQ; Liang X; Zhang R; Yin H; Choi A; Bennett ES; You M
    Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(1):G38-47. PubMed ID: 23139221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased dietary fat contributes to dysregulation of the LKB1/AMPK pathway and increased damage in a mouse model of early-stage ethanol-mediated steatosis.
    Shearn CT; Smathers RL; Jiang H; Orlicky DJ; Maclean KN; Petersen DR
    J Nutr Biochem; 2013 Aug; 24(8):1436-45. PubMed ID: 23465594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.
    Zhang W; Sun Q; Zhong W; Sun X; Zhou Z
    Alcohol Clin Exp Res; 2016 May; 40(5):988-99. PubMed ID: 27062444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin and alcoholic fatty liver disease.
    Rogers CQ; Ajmo JM; You M
    IUBMB Life; 2008 Dec; 60(12):790-7. PubMed ID: 18709650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading to increased fatty acid oxidation.
    Barroso E; Rodríguez-Calvo R; Serrano-Marco L; Astudillo AM; Balsinde J; Palomer X; Vázquez-Carrera M
    Endocrinology; 2011 May; 152(5):1848-59. PubMed ID: 21363937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice.
    You M; Considine RV; Leone TC; Kelly DP; Crabb DW
    Hepatology; 2005 Sep; 42(3):568-77. PubMed ID: 16108051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of mammalian sirtuin 1 in the action of ethanol in the liver.
    You M; Liang X; Ajmo JM; Ness GC
    Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G892-8. PubMed ID: 18239056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lycopene and apo-10'-lycopenoic acid have differential mechanisms of protection against hepatic steatosis in β-carotene-9',10'-oxygenase knockout male mice.
    Ip BC; Liu C; Lichtenstein AH; von Lintig J; Wang XD
    J Nutr; 2015 Feb; 145(2):268-76. PubMed ID: 25644347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone promotes fatty acyl CoA accumulation and excessive glycogen storage in livers of mice without adiponectin.
    Zhou M; Xu A; Lam KS; Tam PK; Che CM; Chan L; Lee IK; Wu D; Wang Y
    J Hepatol; 2010 Dec; 53(6):1108-16. PubMed ID: 20828853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acanthoic acid protectsagainst ethanol-induced liver injury: Possible role of AMPK activation and IRAK4 inhibition.
    Yao YL; Han X; Song J; Zhang J; Li YM; Lian LH; Wu YL; Nan JX
    Toxicol Lett; 2017 Nov; 281():127-138. PubMed ID: 28964808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.
    Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ
    Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver disease.
    Chen H; Shen F; Sherban A; Nocon A; Li Y; Wang H; Xu MJ; Rui X; Han J; Jiang B; Lee D; Li N; Keyhani-Nejad F; Fan JG; Liu F; Kamat A; Musi N; Guarente L; Pacher P; Gao B; Zang M
    Hepatology; 2018 Aug; 68(2):496-514. PubMed ID: 29457836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of hepatic lipin-1 by ethanol: role of AMP-activated protein kinase/sterol regulatory element-binding protein 1 signaling in mice.
    Hu M; Wang F; Li X; Rogers CQ; Liang X; Finck BN; Mitra MS; Zhang R; Mitchell DA; You M
    Hepatology; 2012 Feb; 55(2):437-46. PubMed ID: 21953514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.